{"uri": "eng-9413382", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Medication", "type": "wiki", "score": 100, "label": {"eng": "Medication"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 79, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Computer_security", "type": "wiki", "score": 55, "label": {"eng": "Computer security"}}, {"uri": "http://en.wikipedia.org/wiki/Therapy", "type": "wiki", "score": 42, "label": {"eng": "Therapy"}}, {"uri": "http://en.wikipedia.org/wiki/Ransomware", "type": "wiki", "score": 42, "label": {"eng": "Ransomware"}}, {"uri": "http://en.wikipedia.org/wiki/Cyberattack", "type": "wiki", "score": 36, "label": {"eng": "Cyberattack"}}, {"uri": "http://en.wikipedia.org/wiki/Endocrine_disease", "type": "wiki", "score": 35, "label": {"eng": "Endocrine disease"}}, {"uri": "http://en.wikipedia.org/wiki/U.S._Securities_and_Exchange_Commission", "type": "wiki", "score": 31, "label": {"eng": "U.S. Securities and Exchange Commission"}}, {"uri": "http://en.wikipedia.org/wiki/Market_capitalization", "type": "wiki", "score": 23, "label": {"eng": "Market capitalization"}}, {"uri": "http://en.wikipedia.org/wiki/Database", "type": "wiki", "score": 23, "label": {"eng": "Database"}}, {"uri": "http://en.wikipedia.org/wiki/Valuation_(finance)", "type": "wiki", "score": 15, "label": {"eng": "Valuation (finance)"}}], "eventDate": "2024-03-20", "totalArticleCount": 8, "title": {"eng": "Crinetics Pharmaceuticals CFO sells shares worth nearly $300k By Investing.com"}, "summary": {"eng": "SAN DIEGO - Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) reported that its Chief Financial Officer, Marc Wilson, has sold shares in the company valued at nearly $300,000, according to a recent filing with the Securities and Exchange Commission.\n\nThe transaction, which took place on March 19, involved the sale of 6,942 shares at an average price of $42.91, amounting to a total of $297,881. The sales were made in a series of open market transactions ranging from $41.04 to $44.00 per share. This sa"}, "location": null, "categories": [{"uri": "dmoz/Business/Investing", "label": "dmoz/Business/Investing", "wgt": 80}, {"uri": "dmoz/Business/Investing/Stocks_and_Bonds", "label": "dmoz/Business/Investing/Stocks and Bonds", "wgt": 68}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals", "wgt": 28}, {"uri": "news/Business", "label": "news/Business", "wgt": 77}], "articleCounts": {"eng": 8}, "sentiment": 0.2078431372549019, "wgt": 448588800, "relevance": 1}